ArticleNeurosurgery practice2025
Myelomeningocele in the Pediatric Neurosurgery Department at Bernard Mevs Hospital in Haiti: A Retrospective Analysis.
Article in Neurosurgery practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveBirth defects occur more often in low-income and middle-income countries. This study delineates the epidemiology of myelomeningocele (MMC) patients presenting to the Bernard Mevs Hospital (HBM) in Haiti.
methodsPediatric patients with MMC at HBM between 2018 and 2022 were reviewed, and statistical analyses were performed.
resultsThe study included 54 spina bifida patients with a mean age of 1.2 ± 2.4 months, predominantly male (64.8%, n = 35). The prevalence from 2018 to 2022 was approximately 0.4 cases per 10 000 live births. Half of the patients (50.0%, n = 27) had a birth weight of 2500 to 4000 g. Hydrocephalus was commonly associated, present in 55.6% (n = 30) of patients. Lumbar defects were most frequent, found in 63% (n = 34) of cases. The average hospital stay was 31.3 ± 43.5 days, with 94.4% (n = 51) showing clinical improvement; there were 3 deaths (5.6%). Regarding timing of intervention, 25.9% (14/54) underwent early repair and 74.1% (40/54) late repair. Hydrocephalus was present in 64.3% of the early group and 52.5% of the late group (
conclusionThe study highlights the epidemiology of MMC at HBM, with a high prevalence of hydrocephalus and lumbar defects. Shorter postoperative stays were linked to better outcomes. The findings highlight the need for improved prenatal care, folate supplementation, and addressing socioeconomic challenges to improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.